The report, “Attracting Life Science Investments in Europe,” has been published in 2023 as an initiative by BioMed Alliance, EuropaBio, and Johnson & Johnson. The report consists of an analysis of the life science sector within Europe, providing a set of indicators on the importance of life science investments.
The report identifies existing gaps within the European life science ecosystem compared to the US and China and provides strategic recommendations to address these disparities. Key recommendations include:
- Stronger policy efforts from the EU to establish a long-term vision and enhance Europe’s position in life sciences.
- Increased and more focused public funding for research and education, both at the EU level and within individual member states, to avoid the inefficiencies caused by fragmented resources